You are here

Our science / Clinical Trials / Find a Trial / NCT02406560

A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food

Back to Search Print Save as PDF Bookmark Trial

NCT02406560

Last updated on February 17, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Clinical Research Unit
Brussels, , B-1070 Belgium
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Volunteers
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Index (BMI) of 17.5 to 30.5 and total body weight more than 50 kg (110 lbs).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

(systolic) or 90 mg Hg (diastolic). - Use of prescription or nonprescription drugs
supplements within 7 days prior to 7 days of the study.

NCT02406560
Pfizer
Completed
A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Healthy Volunteers
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
NCT03273842
All Genders
18+
Years
Multiple Sites
Healthy Volunteers
Multiple Ascending Dose and DDI Study
NCT03031119
All Genders
18+
Years
Brussels,
Healthy Volunteers
A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects
NCT01893866
All Genders
18+
Years
Brussels,
Healthy Volunteers
A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804
NCT01313793
All Genders
18+
Years
Bruxelles,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now